KEY DATA: According to DRG research share of physicians seeing reps in-person dropped from 67% to 54%. Most notably, physician respondents highlighted a time crunch as the primary cause for less in-person time, with increased patient loads, EHR maintenance and time spent on other bureaucratic tasks resulting in less available time to meet with pharma representatives.